Back
Nanobiotix SA 10K Form
Sell
35
NBTX
Nanobiotix SA
Last Price:
3.80
Seasonality Move:
6.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NBTX News And Ratings
See the #1 stock for the next 7 days that we like better than NBTX
NBTX Financial Statistics
Sales & Book Value
Annual Sales: | $32.54M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.49 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.79680 |
---|---|
Net Income (TTM): | $-36.04M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | -44.94% |
Nanobiotix SA Earnings Forecast
Key Nanobiotix SA Financial Ratios
- The Research & Development expenses have been 127.74% of Revenue.
- The Interest Expense is -20.11% of Operating Income.
- The Net Earning history of NBTX is -132.08% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 4 years.
Nanobiotix SA Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | NBTX |
CUSIP: | 63009J |
Website: | nanobiotix.com |
Debt
Debt-to-Equity Ratio: | -2.04 |
---|---|
Current Ratio: | 1.42 |
Quick Ratio: | 1.38 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
NBTX Technical Analysis vs Fundamental Analysis
Sell
35
Nanobiotix SA (NBTX)
is a Sell
Is Nanobiotix SA a Buy or a Sell?
-
Nanobiotix SA stock is rated a Sell
The current Nanobiotix SA [NBTX] share price is $4.07. The Score for NBTX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.